Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
151 |
|
| Actual shortage: | 6 (4%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 4 (3%) | |
| Resolved: | 139 (92%) | |
Discontinuation Reports |
51 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 51 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-04-27 | 2018-05-25 | 47334 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-07-05 | 2018-07-21 | 54449 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2019-03-21 | 2019-04-18 | 79161 |
| FLAREX | 0.1% | SUSPENSION | Resolved | 2017-07-13 | 2017-07-27 | 15722 |
| TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2017-06-23 | 2017-07-11 | 13861 |
| TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2017-07-27 | 2017-09-13 | 17414 |
| TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2017-09-18 | 2017-11-02 | 22359 |
| TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2018-12-19 | 2019-02-02 | 70039 |
| TOBRADEX | 0.1% 0.3% | SUSPENSION | Resolved | 2017-09-05 | 2017-09-14 | 20969 |
| TOBRADEX | 0.1% 0.3% | SUSPENSION | Resolved | 2022-07-21 | 2022-08-06 | 165184 |
| DUREZOL | 0.05% | EMULSION | Resolved | 2018-04-18 | 2018-04-20 | 46280 |
| DUREZOL | 0.05% | EMULSION | Resolved | 2018-08-28 | 2018-10-04 | 59387 |
| DUREZOL | 0.05% | EMULSION | Resolved | 2019-08-13 | 2019-11-07 | 91488 |
| DUREZOL | 0.05% | EMULSION | Resolved | 2022-01-12 | 2024-04-05 | 152583 |
| DUREZOL | 0.05% | EMULSION | Resolved | 2023-10-23 | 2024-03-06 | 207835 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2018-01-08 | 2018-02-08 | 35254 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2018-03-13 | 2018-04-25 | 42773 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2019-12-16 | 2019-12-19 | 101440 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2020-01-20 | 2020-04-17 | 103742 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2020-05-05 | 2020-05-21 | 114097 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-11-26 | 2020-11-26 | 128967 |
| SANDOSTATIN | 100MCG | SOLUTION | Discontinued | 2024-03-22 | 2024-03-22 | 223070 |
| ARZERRA | 1000MG | SOLUTION | Discontinued | 2019-03-11 | 2019-03-12 | 78219 |
| TRANSDERM-NITRO 0.6 | 0.6MG | PATCH (EXTENDED RELEASE) | Discontinued | 2021-05-05 | 2022-01-17 | 138767 |
| LIORESAL INTRATHECAL 0.5MG/ML | 0.5MG | SOLUTION | Discontinued | 2023-08-17 | 2023-09-19 | 202298 |
| TRANSDERM-NITRO 0.4 | 0.4MG | PATCH (EXTENDED RELEASE) | Discontinued | 2020-07-10 | 2020-12-21 | 119964 |
| EXTAVIA | 0.3MG | POWDER FOR SOLUTION | Discontinued | 2022-01-12 | 2022-02-11 | 152532 |
| TRANSDERM-NITRO 0.2 | 0.2MG | PATCH (EXTENDED RELEASE) | Discontinued | 2020-07-10 | 2020-12-21 | 119960 |
| BETOPTIC S | 0.25% | SUSPENSION | Discontinued | 2022-09-28 | 2023-01-19 | 170389 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Discontinued | 2019-09-11 | 2019-11-07 | 93561 |
| LIORESAL INTRATHECAL 0.05MG/ML | 0.05MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201576 |